1. Donohue RE, Utley WL. Torsion of spermatic cord. Urology. 1978; 11:33–36. PMID:
622758.
Article
2. Anderson JB, Williamson RC. Testicular torsion in Bristol: a 25-year review. Br J Surg. 1988; 75:988–992. PMID:
3219547.
Article
3. Ames BN. Endogenous oxidative DNA damage, aging, and cancer. Free Radic Res Commun. 1989; 7:121–128. PMID:
2684796.
Article
4. de Groot H, Rauen U. Ischemia-reperfusion injury: processes in pathogenetic networks: a review. Transplant Proc. 2007; 39:481–484. PMID:
17362763.
Article
5. Granger DN, Korthuis RJ. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol. 1995; 57:311–332. PMID:
7778871.
Article
6. Yang S, Shih HJ, Chow YC, Tsai PS, Huang CJ. Hemin induced heme oxygenase-1 over expression involves nuclear factor-E2 related factor-2, nuclear factor-kappaB and extracellular regulated kinase: an experimental study in a testicular torsion-detorsion rodent model. J Urol. 2008; 179:2456–2463. PMID:
18433787.
7. Altavilla D, Romeo C, Squadrito F, Marini H, Morgia G, Antonuccio P, Minutoli L. Molecular pathways involved in the early and late damage induced by testis ischemia: evidence for a rational pharmacological modulation. Curr Med Chem. 2012; 19:1219–1224. PMID:
22300051.
8. Orrenius S, Nobel CS, van den Dobbelsteen DJ, Burkitt MJ, Slater AF. Dithiocarbamates and the redox regulation of cell death. Biochem Soc Trans. 1996; 24:1032–1038. PMID:
8968507.
Article
9. Iseki A, Kambe F, Okumura K, Niwata S, Yamamoto R, Hayakawa T, Seo H. Pyrrolidine dithiocarbamate inhibits TNF-alpha-dependent activation of NF-kappaB by increasing intracellular copper level in human aortic smooth muscle cells. Biochem Biophys Res Commun. 2000; 276:88–92. PMID:
11006087.
10. Liu SF, Ye X, Malik AB. Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. Circulation. 1999; 100:1330–1337. PMID:
10491379.
11. Bowie A, O'Neill LA. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol. 2000; 59:13–23. PMID:
10605930.
12. Schreck R, Meier B, Männel DN, Dröge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med. 1992; 175:1181–1194. PMID:
1314883.
Article
13. Borrello S, Demple B. NF kappa B-independent transcriptional induction of the human manganous superoxide dismutase gene. Arch Biochem Biophys. 1997; 348:289–294. PMID:
9434740.
14. Liu SF, Ye X, Malik AB. In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol. 1997; 159:3976–3983. PMID:
9378986.
15. Si X, McManus BM, Zhang J, Yuan J, Cheung C, Esfandiarei M, Suarez A, Morgan A, Luo H. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway. J Virol. 2005; 79:8014–8023. PMID:
15956547.
Article
16. Hartsfield CL, Alam J, Choi AM. Transcriptional regulation of the heme oxygenase 1 gene by pyrrolidine dithiocarbamate. FASEB J. 1998; 12:1675–1682. PMID:
9837857.
Article
17. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978; 86:271–278. PMID:
655387.
18. Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 1991; 196:143–151. PMID:
2029780.
Article
19. Saba M, Morales CR, De Lamirande E, Gagnon C. Morphological and biochemical changes following acute unilateral testicular torsion in prepubertal rats. J Urol. 1997; 157:1149–1154. PMID:
9072560.
Article
20. Németh ZH, Haskó G, Vizi ES. Pyrrolidine dithiocarbamate augments IL-10, inhibits TNF-alpha, MIP-1alpha, IL-12, and nitric oxide production and protects from the lethal effect of endotoxin. Shock. 1998; 10:49–53. PMID:
9688091.
21. Sun Z, Andersson R. NF-kappaB activation and inhibition: a review. Shock. 2002; 18:99–106. PMID:
12166787.
22. Frossard JL, Pastor CM, Hadengue A. Effect of hyperthermia on NF-kappaB binding activity in cerulein-induced acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2001; 280:G1157–G1162. PMID:
11352808.
23. Orfila C, Lepert JC, Alric L, Carrera G, Béraud M, Pipy B. Immunohistochemical distribution of activated nuclear factor kappaB and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats. Histochem Cell Biol. 2005; 123:585–593. PMID:
15959796.
24. Tugcu V, Ozbek E, Tasci AI, Kemahli E, Somay A, Bas M, Karaca C, Altug T, Cekmen MB, Ozdogan HK. Selective nuclear factor kappa-B inhibitors, pyrolidium dithiocarbamate and sulfasalazine, prevent the nephrotoxicity induced by gentamicin. BJU Int. 2006; 98:680–686. PMID:
16925772.
25. Gu EY, Han HS, Park JS. Effect of minocycline on activation of glia and nuclear factor kappa B in an animal nerve injury model. Korean J Physiol Pharmacol. 2004; 8:237–243.
26. Hidaka S, Funakoshi T, Shimada H, Tsuruoka M, Kojima S. Protective effect of N-benzyl-D-glucamine dithiocarbamate against renal toxicity in rats during repeated cis-diamminedichloroplatinum administrations. Ren Fail. 1995; 17:539–550. PMID:
8570866.
27. Kojima S, Sugimura Y, Ono H, Shimada H, Funakoshi T. N-benzyl-D-glucamine dithiocarbamate and N-p-isopropylbenzyl-D-glucamine dithiocarbamate improve the protective effect of diethyldithiocarbamate against cadmium-induced testicular toxicity in rats. Biol Pharm Bull. 1993; 16:244–247. PMID:
8395932.
Article
28. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB, Abraham E. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med. 1996; 24:1285–1292. PMID:
8706481.
Article
29. Li C, Browder W, Kao RL. Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart. Am J Physiol. 1999; 276:H543–H552. PMID:
9950856.
30. Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension. 2000; 35:193–201. PMID:
10642297.
31. Bach SP, Chinery R, O'Dwyer ST, Potten CS, Coffey RJ, Watson AJ. Pyrrolidinedithiocarbamate increases the therapeutic index of 5-fluorouracil in a mouse model. Gastroenterology. 2000; 118:81–89. PMID:
10611156.
Article
32. Chen D, Peng F, Cui QC, Daniel KG, Orlu S, Liu J, Dou QP. Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis. Front Biosci. 2005; 10:2932–2939. PMID:
15970547.
Article
33. Morais C, Pat B, Gobe G, Johnson DW, Healy H. Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines. Nephrol Dial Transplant. 2006; 21:3377–3388. PMID:
16998220.
Article
34. Arima N, Arimura K, Tokito Y, Sakaki Y, Matsushita K, Orihara K, Akimoto M, Ozaki A, Kukita T, Hagiwara T, Hamada H, Tei C. HTLV-I Tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an anti-oxidant, in adult T cell leukemia cells. Exp Hematol. 2004; 32:195–201. PMID:
15102481.
Article
35. Milacic V, Chen D, Giovagnini L, Diez A, Fregona D, Dou QP. Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity. Toxicol Appl Pharmacol. 2008; 231:24–33. PMID:
18501397.
Article
36. Chae HJ, Bae J, Chae SW. PDTC Inhibits TNF-α-Induced Apoptosis in MC3T3E1 Cells. Korean J Physiol Pharmacol. 2003; 7:199–206.
37. Zhang H, Wu JS, Peng F. Potent anticancer activity of pyrrolidine dithiocarbamate-copper complex against cisplatin-resistant neuroblastoma cells. Anticancer Drugs. 2008; 19:125–132. PMID:
18176108.
Article
38. Chatterjee PK, di Villa Bianca RD, Sivarajah A, McDonald MC, Cuzzocrea S, Thiemermann C. Pyrrolidine dithiocarbamate reduces renal dysfunction and injury caused by ischemia/reperfusion of the rat kidney. Eur J Pharmacol. 2003; 482:271–280. PMID:
14660032.
Article
39. Li J, Sheng W, Feng C, Zuo Z. Pyrrolidine dithiocarbamate attenuates brain Aβ increase and improves long-term neurological outcome in rats after transient focal brain ischemia. Neurobiol Dis. 2012; 45:564–572. PMID:
21983158.
Article
40. Teke Z, Kabay B, Aytekin FO, Yenisey C, Demirkan NC, Sacar M, Erdem E, Ozden A. Pyrrolidine dithiocarbamate prevents 60 minutes of warm mesenteric ischemia/reperfusion injury in rats. Am J Surg. 2007; 194:255–262. PMID:
17618816.
Article
41. Teke Z, Aytekin FO, Kabay B, Yenisey C, Aydin C, Tekin K, Sacar M, Ozden A. Pyrrolidine dithiocarbamate prevents deleterious effects of remote ischemia/reperfusion injury on healing of colonic anastomoses in rats. World J Surg. 2007; 31:1835–1842. PMID:
17566823.
Article
42. Mallick IH, Yang WX, Winslet MC, Seifalian AM. Pyrrolidine dithiocarbamate reduces ischemia-reperfusion injury of the small intestine. World J Gastroenterol. 2005; 11:7308–7313. PMID:
16437633.
Article
43. Tian XF, Yao JH, Li YH, Gao HF, Wang ZZ, Yang CM, Zheng SS. Protective effect of pyrrolidine dithiocarbamate on liver injury induced by intestinal ischemia-reperfusion in rats. Hepatobiliary Pancreat Dis Int. 2006; 5:90–95. PMID:
16481291.
44. Kabay B, Teke Z, Aytekin FO, Yenisey C, Bir F, Sacar M, Erdem E, Ozden A. Pyrrolidine dithiocarbamate reduces lung injury caused by mesenteric ischemia/reperfusion in a rat model. World J Surg. 2007; 31:1707–1715. PMID:
17551782.
Article
45. El Eter E, Hagar HH, Al-Tuwaijiri A, Arafa M. Nuclear factor-kappaB inhibition by pyrrolidinedithiocarbamate attenuates gastric ischemia-reperfusion injury in rats. Can J Physiol Pharmacol. 2005; 83:483–492. PMID:
16049548.
46. Ilbey YO, Ozbek E, Simsek A, Cekmen M, Otunctemur A, Somay A. Chemoprotective effect of a nuclear factor-kappaB inhibitor, pyrrolidine dithiocarbamate, against cisplatin-induced testicular damage in rats. J Androl. 2009; 30:505–514. PMID:
19234314.